Elen Rozler

Title: Elen Rozler: Innovator in Hematopoietic Stem Cell Research

Introduction

Elen Rozler is a notable inventor based in Mountain View, CA (US), recognized for his contributions to the field of hematopoietic stem cell research. With a total of 2 patents, Rozler has made significant advancements in methods for obtaining compositions enriched for hematopoietic stem cells.

Latest Patents

Rozler's latest patents focus on innovative methods involving a novel antibody, designated the .alpha.EM10 antibody. This invention provides methods for determining hematopoietic stem cell content by employing antibodies specific for a unique cell marker (EM10) expressed on stem cells. Additionally, he has developed methods to obtain compositions enriched for hematopoietic stem cells using a hybridoma cell line that produces the .alpha.EM10 antibody. These methods utilize a separation technique that targets the EM10 marker, which is less accessible or absent on more mature cells, thereby enriching cell compositions for EM10+ cells.

Career Highlights

Throughout his career, Elen Rozler has worked with various organizations, including Systemix, Inc. His work has significantly impacted the understanding and application of hematopoietic stem cells in medical research and therapies.

Collaborations

Rozler has collaborated with notable colleagues, including Benjamin P. Chen and Beth Louise Hill, who have contributed to his research endeavors.

Conclusion

Elen Rozler's innovative work in hematopoietic stem cell research has led to valuable patents that enhance the understanding and application of stem cell technology. His contributions continue to influence the field and pave the way for future advancements.